Connor, Clark & Lunn Investment Management (CC&L)’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-48,791
Closed -$390K 1470
2024
Q3
$390K Sell
48,791
-71,796
-60% -$574K ﹤0.01% 1159
2024
Q2
$1.05M Sell
120,587
-44,525
-27% -$387K ﹤0.01% 836
2024
Q1
$3.41M Buy
165,112
+41,348
+33% +$855K 0.01% 517
2023
Q4
$2.86M Buy
+123,764
New +$2.86M 0.01% 581